Invitrogen™ Human NSE ELISA Kit

Ref.: BL-RE-093199Manufacturer ref.: EEL040 96 Tests
€694.00 excl. VAT

Neuron specific enolase (NSE, ENO1, ENO2, ENO3) is an enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway, and the reverse reaction in gluconeogenesis. NSE has a high stability in biological…

Accession number
P09104
Dose range
2.34 to 150 ng/mL
Sensitivity of the dosage
1.4 ng/mL
Conjugate
HRP
Product type
ELISA
Brand
Invitrogen

Neuron specific enolase (NSE, ENO1, ENO2, ENO3) is an enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway, and the reverse reaction in gluconeogenesis. NSE has a high stability in biological…

Neuron specific enolase (NSE, ENO1, ENO2, ENO3) is an enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway, and the reverse reaction in gluconeogenesis. NSE has a high stability in biological fluids and can easily diffuse to the extracellular medium and cerebrospinal fluid (CSF) when neuronal membranes are injured.NSE is one of three mammalian enolases, which are also known as ENO1, ENO2, and ENO3 or alternately as enolase alpha, beta and gamma. The alpha-subunit is expressed in most tissues, the beta-subunit only in muscle, and the gamma-subunit is expressed primarily in neurons, in normal and in neoplastic neuroendocrine cells. Co-expression of NSE and chromogranin A is common in neuroendocrine neoplasms. Since neurons require a great deal of energy, they are very rich in glycolytic enzymes such a GAPDH and NSE. Antibodies to NSE protein are useful to identify neuronal cell bodies, developing neuronal lineage and neuroendocrine cells. Release of NSE from damaged neurons into CSF and blood has also been used as a biomarker of neuronal injury. NSE is used clinically as a sensitive and useful marker of neuronal damage in several neurological disorders including stroke, hypoxic brain damage, status epilepticus, Creutzfeldt-Jakob disease, and herpetic encephalitis. Further, NSE is found in elevated concentrations in plasma and certain neoplasias that include pediatric neuroblastoma and small cell lung cancer.

Sensitivity

Sensitivity of dosage: 1.4 ng/mL.

Measurement range

Dose range: 2.34 to 150 ng/mL.

Duration of dosing

Total duration of dosing: 3 h 30 min.

Samples

Type of sample: Plasma (volume 100 µL).

Conjugate

Conjugated: HRP.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)18067454
Specifications
Accession numberP09104
Dose range2.34 to 150 ng/mL
Sensitivity of the dosage1.4 ng/mL
ConjugateHRP
Product typeELISA
Type of samplePlasma
For use with (equipment)Colorimetric Microplate Reader
Genetic identification (Enter)2026
Gene symbol(s)ENO2
Coefficient of inter-dose variation<10%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated 96 well flat, Standard, Biotinylated Detection Antibody, HRP Conjugate, Standard & Sample Dilute, Biotinylated Detection Antibody Dilute, HRP Conjugate Dilute, Wash Buffer, TMB Substrate, Stop Solution, Plate Sealer
Marker or dyeHRP
Quantity96 Tests
Regulatory statusRUO
TargetHuman
Test time1 hr 20 min
Physical characteristics
Volume of sample100 µL
Storage and shipping
Storage conditionsRefer to product documentation for component specific storage temperature.
Total duration of dosing3 hr 30 min

Origin and customs

Manufacturer ref.EEL040
Country of originChina
HS customs code3822 11 00 00
A question or a specific configuration?
Contact us for a quote.